- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02827422
A Prospective, Multicenter Registry With Targeted Temperature Management After Out-of-hospital Cardiac Arrest in Korea
October 19, 2016 updated by: Kyu Nam Park
Therapeutic hypothermia after out-of-hospital cardiac arrest is considered as a standard care.
However, optimal candidates, optimal dose, duration, timing of initiation and rate of rewarming is still unknown.
The objective of this project is to improve the outcomes for patients after resuscitation from out-of-hospital cardiac arrest treated with therapeutic hypothermia established from the analysis of multicenter registry data.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
1800
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Kyu Nam Park, MD, PhD
- Phone Number: 82-2-2258-6301
- Email: emsky@catholic.ac.kr
Study Locations
-
-
-
Seoul, Korea, Republic of, 06591
- Recruiting
- Seoul St. Mary's Hospital, The Catholic University of Korea
-
Contact:
- Kyu Nam Park, MD, PhD
- Phone Number: 82-2-2258-6301
- Email: emsky@catholic.ac.kr
-
Principal Investigator:
- Ji Hoon Kim, MD, PhD
-
Principal Investigator:
- Won Jung Jeong, MD
-
Principal Investigator:
- Seung Pill Choi, MD, PhD
-
Principal Investigator:
- Mi Jin Lee, MD, PhD
-
Principal Investigator:
- Jong-Seok Lee, MD, PhD
-
Principal Investigator:
- Su Jin Kim, MD, PhD
-
Principal Investigator:
- Tae Chang Jang, MD, PhD
-
Principal Investigator:
- Inbyung Kim, MD
-
Principal Investigator:
- Yong Hwan Kim, MD
-
Principal Investigator:
- Won Young Kim, MD, PhD
-
Principal Investigator:
- Jonghwan Jonghwan, MD
-
Principal Investigator:
- Ji Hwan Lee, MD
-
Principal Investigator:
- Giwoon Kim, MD
-
Principal Investigator:
- Wook-jin Choi, MD, PhD
-
Principal Investigator:
- Joo Suk Oh, MD PhD
-
Principal Investigator:
- Chul Han, MD, PhD
-
Principal Investigator:
- Byung Kook Lee, MD, PhD
-
Principal Investigator:
- Taeoh Jeong, MD, PhD
-
Principal Investigator:
- Dong Hoon Lee, MD, PhD
-
Principal Investigator:
- Jin Hong Min, MD
-
Principal Investigator:
- Gyu Chong Cho, MD, PhD
-
Principal Investigator:
- Young Hwan Lee, MD
-
Principal Investigator:
- In Soo Cho, MD
-
Principal Investigator:
- Je Sung You, MD, PhD
-
Principal Investigator:
- Changsun Kim, MD. PhD
-
Principal Investigator:
- Kyoung-Chul Cha, MD
-
Principal Investigator:
- Soo Hyung Cho, MD. PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
patients treated with therapeutic hypothermia after out-of-hospital cardiac arrest.
Description
Inclusion Criteria:
- age of older than 18 years
- out-of-hospital cardiac arrest
- comatose mentality after return of spontaneous circulation (ROSC)
- treated with therapeutic hypothermia, regardless of target temperature
Exclusion Criteria:
- suspected or confirmed to cerebrovascular accident
- poor pre-arrest neurologic status (CPC>3)
- patients who are terminally ill or for whom intensive care dose not seem to be appropriate
- Do not attempt resuscitation (DNAR) order
- patients with tympanic membrane temperature below 30 degree celsius on admission
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
survival
Time Frame: 6 months after cardiac arrest
|
6 months after cardiac arrest
|
|
Neurologic Outcome
Time Frame: 6 months after cardiac arrest
|
Cerebral Performance Category (CPC).
CPC 1,2 : Good Outcome CPC 3,4,5 : Poor Outcome
|
6 months after cardiac arrest
|
Neurologic Outcome
Time Frame: after 6 months
|
modified Rankin Scale (mRS) mRS 0,1,2, 3 : Good Outcome mRS 4,5,6 : Poor Outcome
|
after 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
survival
Time Frame: duration of hospitalization, limit 180 days
|
duration of hospitalization, limit 180 days
|
|
neurological outcome
Time Frame: duration of hospitalization, limit 180 days
|
Cerebral Performance Category (CPC).
CPC 1,2 : Good Outcome CPC 3,4,5 : Poor Outcome
|
duration of hospitalization, limit 180 days
|
neurological outcome
Time Frame: duration of hospitalization, limit 180 days
|
modified Rankin Scale (mRS) mRS 0,1,2, 3 : Good Outcome mRS 4,5,6 : Poor Outcome
|
duration of hospitalization, limit 180 days
|
Survival
Time Frame: 1 month after cardiac arrest
|
1 month after cardiac arrest
|
|
neurological outcome
Time Frame: 1 month after cardiac arrest
|
Cerebral Performance Category (CPC).
CPC 1,2 : Good Outcome CPC 3,4,5 : Poor Outcome
|
1 month after cardiac arrest
|
neurological outcome
Time Frame: 1 month after cardiac arrest
|
modified Rankin Scale (mRS) mRS 0,1,2, 3 : Good Outcome mRS 4,5,6 : Poor Outcome
|
1 month after cardiac arrest
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kyu Nam Park, MD. PhD, Seoul St. Mary's Hospital, The Catholic University of Korea
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2015
Primary Completion (Anticipated)
June 1, 2019
Study Completion (Anticipated)
June 1, 2019
Study Registration Dates
First Submitted
July 5, 2016
First Submitted That Met QC Criteria
July 6, 2016
First Posted (Estimate)
July 11, 2016
Study Record Updates
Last Update Posted (Estimate)
October 21, 2016
Last Update Submitted That Met QC Criteria
October 19, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015-P33001-00
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Out-of-Hospital Cardiac Arrest
-
Medical University of ViennaLudwig Boltzmann Institute Digital Health and Patient Safety; Emergency Medical...RecruitingCardiac Arrest, Out-Of-HospitalAustria
-
University Medical Centre MariborOHK Medical DevicesRecruiting"The Effect of the Use of an Autotransfusion Device on Hemodynamic Parameters During Resuscitation".Cardiac Arrest | Out of Hospital Cardiac ArrestSlovenia
-
National Taiwan University HospitalRecruitingOut-Of-Hospital Cardiac ArrestTaiwan
-
Far Eastern Memorial HospitalRecruitingOut-Of-Hospital Cardiac ArrestTaiwan
-
King's College LondonKing's College Hospital NHS Trust; London Ambulance Service NHS TrustNot yet recruiting
-
Wroclaw Medical UniversityWroclaw Emergency Medical ServicesRecruiting
-
Sunnybrook Health Sciences CentrePrescott-Russell Paramedic Service; Peterborough Paramedic Service; Bruce County... and other collaboratorsRecruiting
-
Emergency Medical Services, Capital Region, DenmarkTrygFonden, Denmark; Danish Heart Foundation; Zoll Medical CorporationRecruitingOut-Of-Hospital Cardiac ArrestDenmark
-
Guy's and St Thomas' NHS Foundation TrustLondon School of Hygiene and Tropical Medicine; King's College London; King's... and other collaboratorsActive, not recruitingOut-Of-Hospital Cardiac ArrestUnited Kingdom
-
National Taiwan University HospitalCompletedOut-Of-Hospital Cardiac ArrestTaiwan
Clinical Trials on not provided
-
The University of Hong KongFood and Health Bureau, Hong Kong GovernmentActive, not recruiting
-
National Medical Research Center for Therapy and...N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow...Completed
-
Acute Leukemia French AssociationCompletedAcute Myeloblastic Leukemia Core Binding FactorFrance
-
National Research Center for Preventive MedicineCompletedAdherence, PatientRussian Federation
-
St. Antonius HospitalCompletedMicrocirculationNetherlands
-
Assistance Publique - Hôpitaux de ParisEuropean Association of Cardiovascular ImagingNot yet recruitingAortic Valve Stenosis | Aortic Valve Disease | Heart Valve Diseases | Mitral Valve Insufficiency | Aortic Valve Insufficiency | Mitral Valve Stenosis | Aortic Valve Stenosis With Insufficiency | Tricuspid Valve Insufficiency | Mitral Valve Disease | Tricuspid Valve Disease | Mitral Valve Insufficiency and... and other conditionsFrance
-
National Institute of Allergy and Infectious Diseases...Completed
-
Pei-Hsin YangCompleted
-
Aimmune Therapeutics, Inc.Completed
-
Yale UniversityCompletedSkin Diseases | Immune System Diseases | Hypersensitivity | Hypersensitivity, Immediate | Skin Diseases, Genetic | Dermatitis | Eczema | Skin Diseases, Eczematous | Dermatitis, Atopic | Genetic Disease, InbornUnited States